Literature DB >> 1652996

Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease.

M Vyberg1, P Leth.   

Abstract

One hundred forty eight liver needle biopsies, comprising 88 consecutive biopsies from patients with clinically diagnosed or suspected alcoholic liver disease and 60 selected biopsies from non-alcoholics, were immunostained for the cell stress protein ubiquitin (Ub). Ub + cells were detected in all of 33 biopsies with alcoholic hepatitis (AH). Practically all Mallory bodies (MBs) showed intense Ub-staining. In addition, many cells revealed Ub + granules lying aggregated (pre-MBs) or dispersed in the cytoplasm of ballooned cells. The mean number of Ub + cells in 10 biopsies with AH was more than 30 times the number of MBs and more than 6 times the number of MBs + pre-MBs found in adjacent Haematoxylin-Eosin (HE) stained sections. Among 55 biopsies from alcoholic patients without AH (i.e. without MBs or pre-MBs in HE stained sections), Ub + cells occurred in eight (14.5%). Among the 60 selected biopsies from non-alcoholic patients with liver diseases in which hepatocyte ballooning and occasionally MBs are seen, a few Ub + cells were revealed in two out of ten with primary biliary cirrhosis (one of which also showed MBs) but none in biopsies with primary sclerosing cholangitis, long-standing large duct obstruction, or various hepatitides. Thus Ub-immunostaining appears to be a highly sensitive and specific method in the detection of MBs and MB precursor stages, making it a valuable tool in the study of alcoholic liver disease, and particularly a more objective method (compared to conventional staining methods) of diagnosing alcoholic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652996

Source DB:  PubMed          Journal:  APMIS Suppl        ISSN: 0903-465X


  1 in total

Review 1.  Mallory-Denk Bodies in chronic hepatitis.

Authors:  Metin Basaranoglu; Nesrin Turhan; Abdullah Sonsuz; Gökcen Basaranoglu
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.